Correction to "Gossypetin Prevents the Progression of Nonalcoholic Steatohepatitis by Regulating Oxidative Stress and AMP-Activated Protein Kinase".

IF 3.2 3区医学 Q2 PHARMACOLOGY & PHARMACY Molecular Pharmacology Pub Date : 2023-12-15 DOI:10.1124/molpharm.123.000675err

引用次数: 0

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

格桑吡丁通过调节氧化应激和 AMP 激活蛋白激酶防止非酒精性脂肪性肝炎恶化》的更正。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文去求助

来源期刊

Molecular Pharmacology 医学-药学

CiteScore

7.20

自引率

2.80%

发文量

审稿时长

3-6 weeks

期刊介绍： Molecular Pharmacology publishes findings derived from the application of innovative structural biology, biochemistry, biophysics, physiology, genetics, and molecular biology to basic pharmacological problems that provide mechanistic insights that are broadly important for the fields of pharmacology and toxicology. Relevant topics include: Molecular Signaling / Mechanism of Drug Action Chemical Biology / Drug Discovery Structure of Drug-Receptor Complex Systems Analysis of Drug Action Drug Transport / Metabolism

期刊最新文献

Bioengineered miR-7-5p modulates non-small cell lung cancer cell metabolism to improve therapy. Evaluation of allosteric N-methyl-d-aspartate receptor modulation by GluN2A-selective antagonists using pharmacological equilibrium modeling. Modeling the contribution of cardiac fibroblasts in dilated cardiomyopathy using induced pluripotent stem cells. Repurposing lapatinib as a triple antagonist of chemokine receptors 3, 4, and 5. Role of the G protein-coupled receptor kinase 2/3 N terminus in discriminating the endocytic effects of opioid agonist drugs.